Medication info
Diabex 250 mg Tablets (Metformin Hydrochloride)

Diabex 250 mg Tablets (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›250mg / 1 tablet
Manufacturer / importer
(Daewoong Pharmaceutical)
Appearance
It is a white, round film-coated tablet.
Packaging
30 tablets/bottle, 100 tablets/bottle, 1000 tablets/bottle
Approval status
Active

MFDS item code 199400492 · Notified 1994.10.13 · Insurance code 641600380

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
The dose should be determined individually based on drug efficacy and tolerability, and the recommended maximum daily dose should not be exceeded. To reduce gastrointestinal adverse reactions and determine the minimum dose required for adequate glycemic control, this product must be started at a low dose. Take 500mg per dose, 2~3 times daily, with meals. Increase the dose gradually by 500mg each week. When taking up to 2000mg, the dose is usually divided into 2 doses daily, taken in the morning and evening. If taking more than 2000mg, divide the dose into 3 daily doses and take with meals; the maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess response to treatment and determine the minimum effective dose. Measure blood glycated hemoglobin levels approximately every 3 months. The goal of treatment with this product, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when a patient whose blood glucose was controlled by diet alone experiences temporary loss of glycemic control, a short course of this product may be sufficient to achieve an adequate effect. This product may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate [GFR] 45≤~<60mL/min/1.73㎡) who have no other conditions that may increase the risk of lactic acidosis, with the following dose adjustments. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to less than 45ml/min or 45ml/min/1.73㎡, respectively, discontinue this product immediately.
Child dose
Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500mg once daily, taken during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg, administered in 2~3 divided doses.

Ingredients

Manufacturer
(Daewoong Pharmaceutical)

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 diabetes with insufficient blood sugar control
View approved original text

This medication is used for patients with Type 2 diabetes whose blood sugar is not sufficiently controlled by diet and exercise alone, particularly those who are overweight. It can be used alone in adult patients or in combination with other oral hypoglycemic agents or insulin. Additionally, it can also be used as monotherapy or in combination with insulin in children aged 10 years and older and adolescents, thus assisting in diabetes treatment across various age groups. This medication effectively controls blood sugar levels, improving diabetes management.

How to take

Adult dose

The dose should be determined individually based on drug efficacy and tolerability, and the recommended maximum daily dose should not be exceeded. To reduce gastrointestinal adverse reactions and determine the minimum dose required for adequate glycemic control, this product must be started at a low dose. Take 500mg per dose, 2~3 times daily, with meals. Increase the dose gradually by 500mg each week. When taking up to 2000mg, the dose is usually divided into 2 doses daily, taken in the morning and evening. If taking more than 2000mg, divide the dose into 3 daily doses and take with meals; the maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess response to treatment and determine the minimum effective dose. Measure blood glycated hemoglobin levels approximately every 3 months. The goal of treatment with this product, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when a patient whose blood glucose was controlled by diet alone experiences temporary loss of glycemic control, a short course of this product may be sufficient to achieve an adequate effect. This product may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate [GFR] 45≤~<60mL/min/1.73㎡) who have no other conditions that may increase the risk of lactic acidosis, with the following dose adjustments. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to less than 45ml/min or 45ml/min/1.73㎡, respectively, discontinue this product immediately.

Child dose

Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500mg once daily, taken during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg, administered in 2~3 divided doses.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so caution is required. It should not be used in patients whose kidney function is moderately impaired or worse, nor in conditions like dehydration, severe infections, or acute myocardial infarction that affect kidney function. Patients with acute and unstable heart failure should also not take this medication. Prior to and after examinations using radiocontrast iodine agents, administration of this medication should be temporarily suspended and can only be resumed once kidney function is confirmed to be normal. It is not indicated for patients with allergies to this medication or similar drugs, Type 1 diabetes, lactic acidosis, or diabetic ketoacidosis. Temporary cessation of use is also necessary prior to and after serious infections, trauma, or surgery, and it should be avoided in patients with poor nutritional status or liver impairment. The use of this medication is also not recommended for pregnant women at risk for placental insufficiency or preeclampsia. During the course of treatment with this medication, irregular meals, excessive exercise, or interactions with other drugs may lead to hypoglycemia or lactic acidosis. This medication may cause side effects such as gastrointestinal disturbances, metallic taste, skin rash, anemia, liver dysfunction, and rarely hypoglycemia; should any unusual symptoms occur, medical consultation is recommended. Kidney function should be regularly monitored, and if there is a decline in function, the medication should be discontinued. Alcohol consumption may increase the risk of lactic acidosis, so it should be avoided while taking this medication. Blood sugar control is very important during pregnancy, so the use of this drug should be carefully considered before and during pregnancy. Since this medication can be excreted in breast milk, breastfeeding status and drug therapy should be discussed with a physician. Elderly individuals often have diminished kidney function, necessitating dosage adjustments and regular monitoring of kidney function. Overdose poses a risk for lactic acidosis, so immediate medical attention is required. This medication may increase the risk of hypoglycemia when used in combination with other hypoglycemic agents, so healthcare providers must be informed of all medications being taken. Regular monitoring of blood sugar and blood tests should be conducted to evaluate treatment effectiveness and side effects during the course of treatment. When administering this medication to children or growing adolescents, careful observation of growth and developmental status is necessary. Lastly, this medication should be stored out of the reach of children and not transferred to another container.

Side effects

  • lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
  • unpleasant taste
Show 11 more
  • metallic taste
  • erythema
  • pruritus
  • urticaria
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • abnormal liver function
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is also advisable to keep it away from direct sunlight and store it at room temperature to maintain its efficacy over time.

Appearance and packaging

Appearance

It is a white, round film-coated tablet.

Package unit

30 tablets/bottle, 100 tablets/bottle, 1000 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.